Axis Biochemicals (Norway) plans homocysteine test launch:
This article was originally published in Clinica
Executive Summary
Axis Biochemicals (Norway) plans to launch an immunoassay for large-scale routine testing of homocysteine next year. Claimed to be the first of its kind, the test measures homocysteine levels for diagnosis of anaemia and as an indicator of cardiovascular disease risk.